Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Company raises the annual revenue guidance from mid-teens to high teens
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Dr. Reddy's Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.
The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.
The vaccine is under FDA review
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Subscribe To Our Newsletter & Stay Updated